Dear Friends and Colleagues,
Cardiovascular Disease remain the leading cause of morbidity and mortality in developed and developing countries although tremendous progress has been reached in the last years concerning the prevention, the understanding of pathophysiology, the diagnostic methods, noninvasive and invasive therapy. This “International Congress of Cardiology: from Scientic Research to Clinical Practice” aim to discuss with an excellent Faculty of national and international scientists from different European countries as well as from USA and Asia, modern aspects in pathophysiology, diagnosis and treatment of different cardiovascular diseases: relevant aspects concerning molecular alterations of troponin in Cardiomyopathies and the progress of high resolution MRI for the diagnosis of this pathology; the continuum from ventricular dysfunction to Heart Failure, the relation with sleep disorders and the new ESC guidelines on Heart Failure. The ESC Guidelines 2016 on Atrial Fibrillation will be discussed analyzing the new pathogenic hypothesis on atrial brillation, the pro and contra of cardioversion versus ablation to restore sinus rhythm and the relevant role of new oral anticoagulant in preventing systemic embolism and stroke. The added contribution of strain in echocardiography in different form of cardiopathy (cardiomyopathy, Valvulopathies, dilated cardiomyopathy, arrhythmias) will be discussed. Cardio-oncology is a new branch of cardiology deriving from the close cooperation of cardiologist and oncologist in the study of cardiac and vascular complication of new anticancer drugs in this pathology second only to cardiovascular disease for morbidity and mortality. New drugs to treat cancer often determine a cardiac damage and only the use of biomarkers and imaging technique, in particular global longitudinal strain reduction and cardiac MRI, may consent a precocious diagnosis of heart failure and vascular damage to start a preventive therapy as evidenced in the 2016 Position Paper of the ESC on Cardio-Oncology. Finally will be discussed the relationship between Cardiometabolic risk and Cardio-vascular events also considering the new Guidelines ESC 2016 in Cardiovascular Prevention. We hope that the Congress will consent an interesting change of ideas and an interactive discussion with Italian cardiologists and, of course, we believe that outside from congress works, all participants may enjoy to visit Palermo, one of the Mediterranean town richer in culture and different historical sites.